Home / News & Events / BIOPRINTIA, new technologies for the personalized treatment of osteoarticular knee pathologies.
Bioprintia is a project subsidized by the CDTI (Center for Industrial Technological Development) within the framework of the Business Leadership in R&D&I program “Misiones” (MIG-20201046). Its main objective is to carry out industrial research into new technologies for the personalized treatment of osteoarticular knee pathologies. This is achieved through the use of artificial intelligence and the creation of cellularized implants generated through 3D bioprinting.